MX2009012233A - Compuestos de triazolil aminopirimidina. - Google Patents

Compuestos de triazolil aminopirimidina.

Info

Publication number
MX2009012233A
MX2009012233A MX2009012233A MX2009012233A MX2009012233A MX 2009012233 A MX2009012233 A MX 2009012233A MX 2009012233 A MX2009012233 A MX 2009012233A MX 2009012233 A MX2009012233 A MX 2009012233A MX 2009012233 A MX2009012233 A MX 2009012233A
Authority
MX
Mexico
Prior art keywords
aminopyrimidine compounds
triazolyl
triazolyl aminopyrimidine
compounds
cancer
Prior art date
Application number
MX2009012233A
Other languages
English (en)
Spanish (es)
Inventor
Jason Scott Sawyer
James Robert Henry
Delu Jiang
Yan Wang
Hong-Yu Li
Harold Burns Brooks
Joyce Z Crich
Melissa Kate Slater
Hong Hu
William Thomas Mcmillen
Sachin Govindlal Maniar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2009012233A publication Critical patent/MX2009012233A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2009012233A 2007-05-16 2008-05-07 Compuestos de triazolil aminopirimidina. MX2009012233A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93833307P 2007-05-16 2007-05-16
PCT/US2008/062799 WO2008144222A2 (en) 2007-05-16 2008-05-07 Triazolyl aminopyrimidine compounds

Publications (1)

Publication Number Publication Date
MX2009012233A true MX2009012233A (es) 2009-12-01

Family

ID=39967594

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012233A MX2009012233A (es) 2007-05-16 2008-05-07 Compuestos de triazolil aminopirimidina.

Country Status (15)

Country Link
US (1) US8114872B2 (enExample)
EP (1) EP2155735A2 (enExample)
JP (1) JP5204838B2 (enExample)
KR (1) KR101131254B1 (enExample)
CN (1) CN101679396B (enExample)
AR (1) AR066472A1 (enExample)
AU (1) AU2008254318B2 (enExample)
BR (1) BRPI0811611A2 (enExample)
CA (1) CA2687474A1 (enExample)
CL (1) CL2008001322A1 (enExample)
EA (1) EA015574B1 (enExample)
MX (1) MX2009012233A (enExample)
PE (1) PE20090803A1 (enExample)
TW (1) TW200902012A (enExample)
WO (1) WO2008144222A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513553A (ja) 2006-12-21 2010-04-30 イーライ リリー アンド カンパニー 癌治療用イミダゾリジノニルアミノピリミジン化合物
CN101563342B (zh) 2006-12-21 2012-09-05 伊莱利利公司 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物
MX2009012228A (es) * 2007-05-16 2009-12-01 Lilly Co Eli Compuesto de triazolil aminopirimidina.
EA015574B1 (ru) 2007-05-16 2011-10-31 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
MX374634B (es) 2013-04-15 2025-03-06 Fmc Corp Star Amidas fungicidas.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2004063192A1 (en) 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7521457B2 (en) * 2004-08-20 2009-04-21 Boehringer Ingelheim International Gmbh Pyrimidines as PLK inhibitors
JP2008510771A (ja) * 2004-08-27 2008-04-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ジヒドロプテリジノン、その製造方法および医薬薬剤としてのその使用
MX2007007032A (es) * 2004-12-17 2007-07-04 Amgen Inc Compuestos de aminopirimidina y metodos de uso.
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8008481B2 (en) 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
CN101563342B (zh) 2006-12-21 2012-09-05 伊莱利利公司 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物
MX2009012228A (es) 2007-05-16 2009-12-01 Lilly Co Eli Compuesto de triazolil aminopirimidina.
EA015574B1 (ru) 2007-05-16 2011-10-31 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения

Also Published As

Publication number Publication date
WO2008144222A3 (en) 2009-01-15
US20100130466A1 (en) 2010-05-27
EA200971067A1 (ru) 2010-04-30
CN101679396B (zh) 2012-06-06
AU2008254318B2 (en) 2012-04-05
AU2008254318A1 (en) 2008-11-27
JP2010527364A (ja) 2010-08-12
JP5204838B2 (ja) 2013-06-05
CA2687474A1 (en) 2008-11-27
US8114872B2 (en) 2012-02-14
PE20090803A1 (es) 2009-07-11
CN101679396A (zh) 2010-03-24
EA015574B1 (ru) 2011-10-31
TW200902012A (en) 2009-01-16
CL2008001322A1 (es) 2009-05-22
AR066472A1 (es) 2009-08-19
BRPI0811611A2 (pt) 2014-11-04
WO2008144222A2 (en) 2008-11-27
KR101131254B1 (ko) 2012-04-24
EP2155735A2 (en) 2010-02-24
KR20090130246A (ko) 2009-12-21

Similar Documents

Publication Publication Date Title
MX2009012228A (es) Compuesto de triazolil aminopirimidina.
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
MY160390A (en) Vinyl indazolyl compounds
IN2012DN00471A (enExample)
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
PL2358697T3 (pl) Związki izoindolinowe do zastosowania w leczeniu raka
AP2960A (en) Substituted pyrimidines for the treatment of diseases such as cancer
MX2009008222A (es) Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama.
MX2009009415A (es) Compuestos de tetrahidroisoquinolina como moduladores del receptor h3 de la histamina.
JO2833B1 (en) Amino pyrazole compound
MY158253A (en) Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
MX2009012233A (es) Compuestos de triazolil aminopirimidina.
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
IL206189A (en) Compounds for use in cancer treatment
WO2008103431A3 (en) Dnai - liposomes
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
MX2011006532A (es) Compuestos anticancerigenos.
ZA201007729B (en) Use of corticotropin-releasing factor for the treatment of cancer
UA101379C2 (en) Amidophenoxyindazoles useful in the treatment of cancer
UA29848U (uk) Застосування системної реконструктивної терапії як способу лікування мігрені
TN2011000013A1 (en) Amidophenoxyindazoles useful as inhibitors of c-met
CY1114071T1 (el) Ενωσεις βινυλοϊνδαζολυλιου
TN2011000545A1 (en) Vinyl indazolyl compounds
ZA200906189B (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer

Legal Events

Date Code Title Description
FG Grant or registration